Inflammatory myofibroblastic tumor of bladder: a clinicopathologic study of five cases.
- Author:
Ke SUN
1
;
Zhao-ming WANG
;
Lin-jie XU
;
Xiao-dong TENG
;
Hong-tian YAO
;
Guo-ping REN
Author Information
- Publication Type:Journal Article
- MeSH: Actins; metabolism; Adolescent; Anion Exchange Protein 1, Erythrocyte; metabolism; Calcium-Binding Proteins; metabolism; Child; Cystectomy; methods; Diagnosis, Differential; Female; Fibrosarcoma; pathology; Follow-Up Studies; Humans; Inflammation; pathology; Leiomyosarcoma; pathology; Male; Microfilament Proteins; metabolism; Middle Aged; Neoplasms, Muscle Tissue; metabolism; pathology; surgery; Protein-Tyrosine Kinases; metabolism; Receptor Protein-Tyrosine Kinases; Rhabdomyosarcoma; pathology; Survival Rate; Urinary Bladder Neoplasms; metabolism; pathology; surgery; Vimentin; metabolism
- From: Chinese Journal of Pathology 2007;36(9):605-608
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the clinicopathologic features, diagnosis and differential diagnosis of inflammatory myofibroblastic tumor of the urinary bladder.
METHODSExcisional specimens from 5 cases of vesical inflammatory myofibroblastic tumor were studied by light microscopy and immunohistochemistry (EnVision). The clinical data were also analyzed.
RESULTSAmong the 5 patients studied, 3 were males and 2 were females. The age of the patients ranged from 10 to 53 years (mean age = 35 years). The most common clinical presentation was micturition pain and hematuria. Three cases were located at the dome of the urinary bladder and the remaining 2 cases were found in the left lateral wall. Histologically, the tumor varied from myxoid to highly cellular. The tumor cells were spindle to stellate in shape, widely separated or showed a compact fascicular pattern. There were often associated with mixed inflammatory infiltrates and an irregular meshwork of small dilated vessels. Immunohistochemical study showed that the tumor cells expressed AE1/AE3 (5/5), vimentin (5/5), smooth muscle actin (5/5), calponin (5/5), caldesmon (3/5), desmin (4/5) and anaplastic lymphoma kinase protein (4/5). Follow-up data were available in 4 patients and none had local recurrence or died of this disease.
CONCLUSIONInflammatory myofibroblastic tumour of urinary bladder is a rarely encountered but distinctive neoplasm with intermediate malignant potential.